Introduction
plays crucial role in activation of various kinases followed by NF-B and activator protein (AP)-1 activation that ultimately triggers downstream effector gene expression, which controls breast cancer progression
. In this study, we report that enhanced level of OPN expression in higher grades of breast tumours correlates with increased NF-B activation, enhanced serine and tyrosine phosphorylation, which further correlated with elevated activation of matrix metalloproteinase-2/-9 (MMP-2/-9) and expression of urokinase-type plasminogen activator (uPA) . [14] [15] [16] [17] [18] . Filleur et al. have reported that intratumoural injection of VEGF siRNA significantly slowed tumour vascularization and growth, which further indicated the potential use of in vivo siRNAbased approach in cancer therapeutics [14] . Accordingly, we hypothesized that intratumoural injection of siRNA specific to OPN could attenuate breast tumour growth in nude mice model.
Several studies have indicated that small interfering RNA (siRNA) targeting to vascular endothelial growth factor (VEGF), epidermal growth factor receptor (EGFR) and other oncogenic molecules results in significant suppression of tumour progression
Recent reports indicated that OPN produced either from tumour or stroma has been shown to enhance the metastatic potential of transformed cells [19] . The decreased rate of tumour invasion to bone was shown in OPN knockout mice as compared to wild-type mice [20] . Moreover recent finding indicated that OPN-knockout mice exhibit a significant delay of tumour development [21] . Therefore we sought to determine whether there is reduced breast tumour growth and neovascularization in OPN -/-mice compared to wild-type mice.
Pristane (2, 6, 10, 14-tetramethylpentadecane) , a naturally occurring isoprenoid is considered as a potent carcinogen [22] . [23] [24] [25] . It has also been reported that pristane can induce skin carcinogenesis [26] . [27] . Pristane-induced tumours exhibit activation of several kinases such as protein kinase C (PKC) [25] and protein kinase A (PKA), enhanced activation of cAMP response element (CRE) [22] [28, 29] . In this study, we sought to determine the role of OPN in pristane-induced mammary tumourigenesis.
Previous reports have shown that intraperitoneal injection of pristane induces plasmocytomas in BALB/c mice

Human breast adenocarcinoma (MCF-7) cells injected to the pristane primed mammary fat pad of virgin female Wistar rat causes development of solid tumours, which have been characterized as adenocarcinoma or fibroadenoma
and c-Myc and increased expression of various molecules such as cyclooxygenase 2 (COX-2), prostaglandin E receptor (EP)-2, EP-4 and inducible nitric oxide synthases (iNOS)
Here 
Materials and methods
Materials
The rabbit anti-OPN polyclonal antibody was purchased from R & D Systems (Minneapolis, MN, USA) . The anti-OPN antibody was also raised against purified intact human OPN in rabbit and characterized in our laboratory as described earlier [30] 
Cell culture
Human breast adenocarcinoma cell line (MDA-MB-231) and non-virally transformed mice breast adenocarcinoma cell line, C127I [31, 32] 
Western blot analysis and EMSA
Western blot and EMSA were performed as described [33, 34] .
Wound migration assay
Wound assay was performed using transfected or non-transfected MDA-MB-231 cells as described [7] .
Gelatin zymography
To determine the gelatinolytic activity of MMP-2 and MMP-9, gelatin zymography was performed using tumour tissue lysates as described earlier [35] .
In vivo xenograft model
MDA-MB-231 (5 ϫ 10
6
) cells were injected orthotopically into the left inguinal mammary fat pad of female nude mice (NMRI) (n = 6/group). After 1 week, OPN-specific siRNA (250 g/kg body weight/mouse) was mixed with siRNA transfection reagent and injected intratumourally as described [14, 36] 
Immunofluorescence analysis
Immunofluorescence studies of human and mice tumours were performed as described earlier [34, 37] . 
Statistical analysis
Results
Expression profiles of OPN, NF-B, uPA, MMP-2 and -9, MT1-MMP and vWF in different grades of human breast cancer specimens and its correlation with tumour progression and angiogenesis
The various histologic grades of breast carcinomas provide clinically important prognostic information [38] . The expression [2] . In this study, we observed the elevated AP-1-DNA-binding in higher grades of specimens (Fig. 1D) . The expression profiles of uPA, MT1-MMP, MMP-2 and MMP-9 were analysed by immunohistochemistry by using their specific antibodies (Fig. 1A , panels VI-IX) and represented in the form of a bar graph (Fig. 1B) (Fig. 3B , panels III and IV and Fig. 3C, panels I-III) . Interestingly, the phosphorylation (serine and tyrosine) status of xenograft tumours of mice was drastically down-regulated in presence of OPN siRNA (Fig. 3C,  panels IV and V) . We have demonstrated earlier in this paper that increased serine and tyrosine phosphorylation correlates with enhanced tumourigenicity in human breast carcinoma specimens (Fig. 1A, panels III and IV) . These data suggested that suppressing tumour-derived OPN not only down-regulates expressions of uPA and MMP-2/-9 but also inhibits total phosphorylations of tyrosine and serine residues of signalling molecules, which ultimately curb breast tumour progression. Moreover, our data also showed that there was reduction of nuclear localization of NF-B in the OPNiinjected tumours (Fig. 3C, panel VI) . EMSA data support these findings and showed that OPNi reduced NF-B and AP-1-DNA binding (Fig. 3D, panels I (Fig. 3C, 
panel VII). These results clearly demonstrated that tumour-derived OPN plays crucial role in regulation of tumour progression and angiogenesis because targeting OPN by its specific siRNA suppresses the expression of oncogenic molecules and down-regulates the neovascularization that ultimately abrogates tumour progression.
Deficiency of host OPN reduces breast tumour growth and suppresses the expression of oncogenic molecules in OPN knock out mice model
To assess breast tumour development in OPN-deficient mice, mice breast adenocarcinoma C127I cells were mixed with growth factor depleted Matrigel as described earlier and implanted orthotropically © 2008 The Authors Journal compilation © 2008 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
Fig. 2 (A and B) MDA-MB-231 cells were transfected with various OPN-specific siRNA (OPNi, see Table 1) and OPN expression was detected by Western blot. Actin was used as loading control. (C) Cells were transfected with OPNi (OPNi1). The levels of pERK, pAkt, uPA, MMP-9 and MMP-2 in cell lysates were analysed using their specific antibodies. Non-phospho ERK, Akt and actin were used as loading controls. Fold changes were calculated. (D) DNA binding of NF-B (panel I) and AP-1 (panel II) were performed from the nuclear extract obtained from control or OPNi transfected MDA-MB-231 cells. (E) Cells were transfected with OPNi or Coni. Wounds of constant diameter were made and wound assay was performed. Photographs were taken at 0 and at 12 hrs under Nikon microscope. The data represent three experiments exhibiting similar results. to the left inguinal mammary fat pad of wild-type and OPN -/-mice. Mice were kept for 8 weeks and then sacrificed. The data indicated that there were significant reductions of breast tumour growth in OPN -/-mice (>5.5 fold) as compared to wild-type mice (Fig. 4A). These data suggested that host OPN also played important role in regulation of breast tumour growth. Histopathological analysis of tumour tissue sections showed that there were significantly higher cellular infiltration, nuclear polymorphism and poorly
Fig. 3 OPN-specific siRNA suppresses breast tumour progression and angiogenesis in nude mice. (A) MDA-MB-231 (5 ϫ 10 6 ) cells were injected orthotopically into the left inguinal mammary fat pad of female nude mice (NMRI) (n = 6/group). After 1 week, OPN-specific siRNA (250 g/kg body weight/mouse) was mixed with siRNA transfection reagent and injected intratumourally, thrice in a week until the completion of experiments. Control group of mice was injected with transfection reagent along with control OPN siRNA 1 (Coni). Typical photographs of orthotropic xenograft tumours are shown (upper panel). Isolated tumours are shown in inset. Note that intratumoural injection of OPNi but not Coni significantly reduced tumour load. Lower panel: The tumour weights were quantified and represented in the form of a bar graph (*P < 0.02) (n = 6). (B and C) Histopathology (haematoxylin and eosin) of the mice breast tumour section. Photographs were taken in 10ϫ and 60ϫ magnification (B, panels I and II). Blood vessels in the tumour section were indicated by black arrows whereas the typical breast lobular structure in OPNi-injected tumours were indicated by blue arrow. Expression profiles of OPN, MMP-2, MMP-9, MT1-MMP and uPA were detected by immunohistochemical studies (B, panels III and IV and C, panels I-III). OPN, MMP-9 and uPA were stained with Cy-3 whereas MT1-MMP was stained with FITC. Nuclei were stained with DAPI. Status of total phosphorylations were shown using anti-phosphoserine and anti-phosphotyrosine antibodies followed by staining with FITC-conjugated IgG (C, panels IV and V). Cellular localization of NF-B, p65 and expression of vWF (neovascularization) were shown by immunofluorescence using their specific antibodies followed by staining with Cy3 conjugated IgG (panels VI and VII). (D) EMSA analysis of NF-B (panel I) and AP-1 (panel II)-DNA binding in tumour tissues. differentiated structure in tumour of wild-type mice as compared to OPN -/-mice (Fig. 4B, panels I and II). The expressions of MMP-9, MMP-2, uPA and MT1-MMP were also detected by immunohistochemistry and the data showed that the expression levels of all these molecules are significantly down-regulated in OPN -/-mice (Fig. 4B, panels IV-VII). Moreover, reduction in tumour vascularization was observed in OPN -/-mice (Fig. 4B, panel VIII). The level of OPN expression in tumour lysates was detected by Western blot and the gelatinolytic activity of MMP-2 and MMP-9 were examined by zymography. The data showed that there were significant reductions of OPN expression (Fig. 4C) and MMP-2 and MMP-9 activation (data not shown) in tumour developed in OPN -/-mice as compared to wild-type mice. Our data also showed the drastic reduction of NF-B and AP-1-DNA binding in tumours of OPN -/-mice, which further indicated that loss of NF-B and AP-1 activation was OPN dependent (Fig. 4D). These data indicated that lack of host OPN expression resulted in reduced expressions of various oncogenic molecules such as MMPs, uPA and down-regulated the activations of NF-B and AP-1 that ultimately suppressed breast tumour growth and angiogenesis.
Pristane induces OPN-dependent mammary tumourigenesis in nude mice
Exposure with external carcinogen is known to induce tumours. Recently it has been reported that carcinogenic compound such as asbestos induces expression of OPN in patients with pleural mesothelioma [39]. To examine the role of external carcinogen in mammary tumourigenesis, we injected pristane, a known natural carcinogen to the mammary fat pad of nude mice and observed that there was significant induction of tumour growth. To determine the role of OPN in pristane-induced breast tumourigenesis, mOPNi was injected intratumourally into the pristane-induced tumours and the data showed that OPNi inhibits pristane-induced mammary tumourigenesis. Tumour weights were measured and the data indicated that injection of mOPNi reduced more than 60% of tumour weight in mice (data not shown). The mammary tumours were also analysed by histopathology. The micrographs of the tumour sections were
taken under microscope (10ϫ and 60ϫ magnifications) (Fig. 5A , panels I and II). The characteristics of these tumours are described in Table 3 . The injection of pristane into the mammary fat pad of nude mice showed poorly differentiated structure with high nuclear polymorphism and large number of mitotic features (Table 3) . Enhanced vascularization was observed in pristane induced but not in OPNi-injected tumours (Fig. 5A, (Fig. 5A, panel III) . (Fig. 5A, panels IV-VI and Fig. 5B, panel I) . OPNi drastically suppressed the pristane-induced expression of these molecules in tumours. Furthermore, the data suggested that pristane not only induced the nuclear localization of NF-B, p65 (indicated by arrows) but also enhanced its DNA binding (Fig. 5B, panel II and Fig. 5C, upper panel) . OPNi suppressed the pristane-induced NF-B nuclear translocation, NF-B and AP-1-DNA binding (Fig. 5B, panel II and Fig. 5C, upper and lower panels) . Moreover, the total phosphorylations of serine and tyrosine residues of signalling molecules were significantly higher in pristane-induced tumours compared to control or OPNi-injected tumours (Fig. 5B, panels III [2] . Therefore, we sought to determine the status of phosphorylations of these kinases in pristane-induced mammary tumours and our data revealed that there were marked inductions of phosphorylations of ERK and Akt in pristane-induced tumours but not in OPNi-injected tumours (Fig. 5B, panels V and VI) . Elevated expression of vWF was also observed in pristine-induced mammary tumours (Fig. 5B, panel VII) . However, OPNi inhibits vWF Figure 6A shows the typical photographs of mice with breast tumours. Our data revealed that there was significant reduction of breast tumour growth (~65%) in OPN -/-mice as compared to wt mice (Fig. 6A) . The tumour sections were analysed histopathologically and the data indicated that there was significant loss of tumourigenicity (less infiltration, well-differentiated structure, reduced mitotic feature) in the OPN -/-mice, whereas enhanced tumourigenesis was observed in pristane-induced wt mice (i.e. enhanced infiltration, poorly differentiated structure, [43, 44] . In recent times, intratumoural delivery of siRNA showed great prospect in cancer therapy particularly in in vivo mice model [14, 36] [45] . These reports prompted us to determine the effect of OPN-specific siRNA in carcinogen-induced tumourigenesis [20] . In contrast, the data also showed that significant alteration of tumour metastasis in bone was not observed in OPN knockout mice [47] . Hsieh 
panels II, indicated by arrows). Immunohistochemical studies with anti-OPN antibody showed that there was marked induction of OPN expression in pristane-induced tumours
These data indicated that injection of pristane resulted in enhanced breast tumour load in nude mice whereas direct delivery of OPNi to the site of pristane-induced tumours showed reduction of the breast tumour growth (Table 3). These findings prompted us to analyse the expression and activation status of various oncogenic molecules and transcriptions factors in these tumour samples. The results indicated the high levels of MMP-9, MMP-2, MT1-MMP and uPA expressions in pristane-induced tumours compared to normal mammary fat pad of nude mice
and IV). Previous reports have indicated that ERK and Akt (tyrosine-and serine-specific kinases) play crucial role in OPN-induced signalling in various cancers
04). (B) Histopathological (haematoxylin and eosin) analysis of mice tumours. Photographs were taken in 10ϫ and 60ϫ magnifications (panels I and II). The expressions of OPN (panel III), MMP-9 (panel IV), MMP-2 (panel V), uPA (panel VI), MT1-MMP (panel VII) and vWF (panel VIII) in mice tumours
Normal mouse mammary fat pad (MFP) is shown as control (panels I and II). Vascularization is indicated by arrows (panel II). Expression profile of OPN was detected by immunofluorescence. Significantly higher level of OPN was observed in pristane-induced tumours whereas silencing of OPN down-regulates tumour-derived OPN expression (panel III). Expressions of MMP-9 (IV), MMP-2 (V) and MT1-MMP (VI) were determined by immunohistochemical analyses using their specific antibodies. (B) Expression of uPA, cellular localization of NF-B and total phosphorylations of serine and tyrosine were analysed by immunohistochemical studies (panels I-IV). Enhanced phosphorylations of ERK and Akt were observed in pristane-induced tumours but not in OPNi-injected tumours and normal tissues (panels V and VI). Tumour sections were stained with anti-vWF antibody to visualize the angiogenesis in these tumours (panel VII). vWF positive areas are indicated by arrows. (C) NF-B (upper panel) and AP-1 (lower panel)-DNA binding in tumour tissues
